Prioritizing and executing strategic decisions with precision is often the biggest challenge faced by healthcare entrepreneurs. Quantifying the impact of an extended Research & Development timeline or the decision to seek additional pilot projects can be unclear—yet the consequences are critical for successful market expansion that can withstand policies and practices.

The presentation will explore:

• The forces changing current market environments
• Methodologies to de-risk assumptions
• Vital information needed for creating and refining market strategy from R&D to BD activities

Join us for the first Learning Series of 2020 as Elizabeth Jennings discusses the best practices to build resilience while managing both offensive and defensive market growth tactics!

Afterwards, join us for happy hour!

The event is sponsored by Schwegman Lundberg & Woessner

About the Speaker:

Elizabeth Jennings is the Founder and Principal of Venture Atlas Labs, a global consultancy. She has vast experience launching new technologies in Healthcare and Life Science and focuses on developing successful commercial and market scenarios for various organizations.

Live Streaming Locations:

The event will be live streamed to additional locations. Please select which location you plan on attending in your response:

• UT Health San Antonio, Center on Smart and Connected Health Technologies, School of Nursing Room 1.120
• UTSA SBDC Technology Commercialization Center, UTSA Downtown Campus; Institute for Economic Development, Durango Building – Room 2.112A , 501 W Cesár E Chavez Blvd, San Antonio, TX 78209
• Temple Health & Bioscience District, 1802 S. 1st Street, Temple, TX 76504